PLGA载IR780光热-光动力纳米体系的构建及其体外抗肿瘤作用OA
Construction of PLGA-Loaded IR780 Nanoplatform for Combined Photothermal-Photodynamic Therapy and Its in Vitro Antitumor Effects
目的 采用聚乳酸-羟基乙酸共聚物(poly lactic-co-glycolic acid,PLGA)制备载IR780的光热-光动力纳米体系(IR780-PLGA-NPs);通过单因素考察优化处方,考察纳米粒的理化性质与体外光热和光动力性能,研究IR780-PLGA-NPs对乳腺癌细胞的抑制效果.方法采用超声乳化法制备IR780-PLGA-NPs,通过单因素法考察药物-聚合物比(drug-to-polymer ratio)、PLGA浓度、表面活性剂浓度、油水相体积比(oil-to-water ratio)等因素对纳米粒的粒径、Zeta电位、多分散指数(polydispersity index,PDI)、载药率和包封率的影响,优化纳米粒制备处方.通过近红外激光照射考察纳米粒的光热及光动力性能,研究不同药物浓度下纳米粒对乳腺癌细胞4T1与MCF-7的光疗抑制作用,并考察其对正常细胞的暗毒性.通过荧光显微镜考察肿瘤细胞对纳米粒的摄取行为,阐明纳米粒增效机制.结果 经过单因素考察优化,制备IR780-PLGA-NPs的最佳处方为:胆酸钠浓度为15 mg/mL,油水比为6.4:10.0,PLGA浓度为18.75 mg/mL,药物-聚合物比为1:24.IR780-PLGA-NPs平均粒径为(135.33±0.49)nm,PDI为(0.255±0.010),Zeta电位为(-10.67±0.09)mV,载药率为(3.43±0.01)%,包封率为(85.79±0.20)%.在体外实验中,IR780-PLGA-NPs相较于游离药物具有更好的光热和光动力效果,能显著抑制乳腺癌细胞的生长,并降低对正常细胞的毒副作用.纳米粒的疗效增强作用与其增强细胞摄取药物、提高药物光热稳定性有关.结论 本研究制备的IR780-PLGA光热-光动力纳米体系可有效抑制乳腺癌细胞生长并降低正常细胞毒性,为其作为抗乳腺癌光疗制剂奠定基础.
Objective The photothermal-photodynamic nano-system(IR780-PLGA-NPs)carrying IR780 was prepared using poly(lactic-co-glycolic acid)(PLGA).The formulation was optimized through single-factor experiments,and the physicochemical properties and in vitro photothermal and photodynamic performances of the nanoparticles were investigated.The inhibitory effect of IR780-PLGA-NPs on breast cancer cells was also studied.Methods IR780-PLGA-NPs were prepared using the ultrasonic emulsifi-cation method.The one-factor-at-a-time approach was used to optimize the formula and investigate the effects of the drug-to-polymer ratio,PLGA concentration,surfactant concentration,and oil-to-water ratio on nanoparticle size,Zeta potential,polydispersity index(PDI),drug loading efficiency,and encapsulation efficiency.The photothermal and photodynamic properties of the nanoparticles were tested under near-infrared laser irradiation.The antitumor effects of the nanoparticles against 4T1 and MCF-7 tumor cells were studied at different concentrations in vitro and their dark toxicity to normal hepatocytes(AML-12 cells)was also evaluated.In addition,the cellular uptake behavior of nanoparticles by tumor cells was also investigated via fluorescence microscopy to elucidate the underlying antitumor mechanism.Results The optimal formulation for preparing IR780-PLGA-NPs was determined as follows:sodium cholate concentration of 15 mg/mL,oil-to-water ratio of 6.4:10.0,PLGA concentration of 18.75 mg/mL,and drug-to-polymer ratio of 1:24.The prepared IR780-PLGA-NPs exhibited an average particle size of(135.33±0.49)nm,PDI of(0.255±0.010),Zeta potential of(-10.67±0.09)mV,drug loading efficiency of(3.43±0.01)%,and encapsulation efficiency of(85.79±0.20)%.In vitro experiments demonstrated that IR780-PLGA-NPs possessed superior photothermal and photodynamic effects compared to free IR780,leading to significantly enhanced inhibition of breast cancer cell growth.Moreover,IR780-PLGA-NPs can reduce the dark cytotoxicity of IR780 to normal hepatocytes.The enhanced antitumor effects of IR780-PLGA-NPs might be related to the higher cellular uptake by tumor cells and improved photothermal stability.Conclusion The PLGA-IR780 photothermal-photodynamic nanosystem prepared in this study can effectively inhibit the growth of breast cancer cells and reduce the toxicity to normal cells,laying the foundation for it to be used as an anti-breast cancer phototherapy agent.
杨佳丽;甘海霞;钟鑫童;范清泽;罗宏丽
西南医科大学附属医院 药学部(泸州 646000)||西南医科大学 药学院(泸州 646000)西南医科大学附属医院 药学部(泸州 646000)||西南医科大学 药学院(泸州 646000)西南医科大学附属医院 药学部(泸州 646000)||西南医科大学 药学院(泸州 646000)西南医科大学附属医院 药学部(泸州 646000)||西南医科大学 药学院(泸州 646000)西南医科大学附属医院 药学部(泸州 646000)
医药卫生
IR780PLGA纳米粒乳腺癌光热光动力
IR780PLGA nanoparticlesBreast cancerPhotothermal therapyPhotodynamic therapy
《西南医科大学学报》 2026 (5)
597-605,9
国家自然科学基金(22208269)四川省大学生创新训练计划项目(S202510632262)
评论